Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$2.80
-0.47-14.37%
Last update: Oct 13, 4:00 PM
Lexaria Bioscience Corp (LEXX) Stock Price, Quote, News & History
LEXXNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Lexaria Bioscience (NASDAQ:LEXX) through any online brokerage.
Other companies in Lexaria Bioscience’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Lexaria Bioscience has a consensus price target of $101.25.
The stock price for Lexaria Bioscience (NASDAQ: LEXX) is $2.8 last updated October 13, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Lexaria Bioscience.
Lexaria Bioscience does not have any upcoming earnings scheduled.
There is no upcoming split for Lexaria Bioscience.
Lexaria Bioscience is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
